“I like the idea of everything being taken out and still having natural breasts, and going from there,” she said.
Aguilar was diagnosed with breast cancer last spring.
Eight weeks later, she was cancer free and feeling great.
“Sometimes I feel like it was a dream, because I knew I had cancer and I have scars to show me what I went through but literally it was two months from diagnosis to surgery, and then finding out I was cancer free,” Aguilar said.
Clark says more women are opting for their natural tissue over implants even if they’re having the surgery as a precaution.
“People who have a BRCA mutation like Angelina Jolie had, we do it for them, and those women will often look like they just had a cosmetic breast lift,” Clark said.
If you have a little extra in other places, that’s OK too.
“We can take the abdominal skin and fat, then we can take the inner thigh,” Clark said. “If there’s a little extra on the bottom we can take that and then you can build up to a size that you want.”
A couple things to keep in mind: One of the things that are really unique about this surgery is doctors are able to preserve the nerves in the tissue. Because of that, the surgery can take up to eight hours or more.
But the recovery is fast, just a two-day hospital stay and minimal pain because the cuts aren’t deep.
Only really thin women aren’t good candidates because there isn’t a lot of fat to use in the reconstruction.
Copyright 2019 KPHO/KTVK (KPHO Broadcasting Corporation). All rights reserved.
Five Stages of Prostate Cancer with Dr. Mark Scholz
Special event with Dr. Mark Scholz will speak on the “Five Stages of Prostate Cancer.”
7-9pm, Friday, Jan. 18, 2019, at Ironwood Cancer & Research Centers at
700 W Warner Rd, Chandler, AZ 85225
About Dr. Scholz
Dr. Scholz is a US/World expert on prostate cancer, is medical director of Prostate Oncology Specialists Inc. in Marina del Rey, CA, and is the executive director of the Prostate Cancer Research Institute (PCRI). You may have attended the PRCI yearly workshops featuring world experts on prostate cancer, and attended by thousands of men seeking an advanced education concerning their disease. Read more about Dr. Scholz here.
CBS Interviewed Dr. Clark about her Article in the Journal of Clinical Oncology
Dr. Patricia Clark was interviewed by journalist Heidi Goitia for CBS 5 This Morning. The video will air later this month and we’ll post it once it’s available. The story was regarding Dr. Clark’s article in the Journal of Clinical Oncology regarding the need to re-examine the national guidelines for who should be tested for genetic predisposition to develop breast or ovarian cancer. Read more about the article that Dr. Clark co-authored here.
Ironwood Breast Surgeon Dr. Patricia Clark Co-Authors Journal of Clinical Oncology Article Underdiagnosis of Hereditary Breast Cancer
On December 7, 2018, an article I co-authored was published in the Journal of Clinical Oncology regarding need to re-examine the national guidelines for who should be tested for genetic predisposition to develop breast or ovarian cancer. We used an 80 gene panel to test over 1,000 patients with breast cancer, half who met NCCN Guidelines recommending genetic testing and half who didn’t. We found no difference in the rate of mutations between the group who met the guidelines and those who didn’t. As a result of this study results, I decided to abandon the national guidelines.
A decade ago, genetic testing for just the BRCA gene could cost over $3,000. Next-generation sequencing and other advancements made panel testing more accessible to the public. Insurers will cover the cost when guideline criteria are met. Even when a patient’s insurance doesn’t cover the testing, the gene panels are $250 or less. Genetic testing for predisposition to breast and ovarian cancer are within reach for most patients and are even available over the Internet.
I now offer genetic testing to all of my breast cancer patients and any patient that requests it regardless of the guidelines. I believe it is important physicians or genetic counselors stay involved in the genetic testing process to ensure patients receive appropriate counseling and follow-up of results with management recommendations. Testing provides peace of mind and gives us the opportunity to either prevent the cancer or to detect at an early stage through appropriate surveillance when the opportunity for cure is highest. It also identifies family members who do not carry the pathological mutations and whose risks are no higher than the general public despite their family history.